FDA Import Refusal AEK-5209613-6/11/1 — ASTRAZENECA
The FDA refused shipment AEK-5209613-6/11/1 from ASTRAZENECA (Thailand) on May 17, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 17, 2024
- Country
- Thailand
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75